The study, sponsored by Johns Hopkins University, investigates the feasibility and tolerability of acupressure and acupuncture as interventions for children with ASD. Given the increasing prevalence of ASD and the growing interest in complementary and alternative medicine, this trial could position acupressure and acupuncture as viable adjunct therapies in the management of ASD. The market for ASD treatments is substantial, with parents actively seeking non-pharmacological options. However, the competitive landscape includes established behavioral therapies and emerging pharmacological treatments, necessitating robust efficacy and safety data to support market entry. Diligence should focus on the scalability of the intervention and potential partnerships with autism advocacy organizations.